Literature DB >> 28501467

Keratitis by a rare pathogen Colletotrichum gloeosporioides: A case report.

S T Pote1, A Chakraborty2, K K Lahiri2, M S Patole1, R A Deshmukh3, S R Shah4.   

Abstract

Colletotrichum species have been reported infrequently as the cause of keratitis or subcutaneous lesions. The patient we describe developed keratitis after ocular trauma. The sample from the corneal scrapings grew Colletotrichum gloeosporioides as identified from morphological characters and DNA sequence of the 'Internal Transcribed Spacer' (ITS) region. The patient underwent topical application of amphotericin-B followed by itraconazole and natamycin treatment. Simultaneous oral voriconazole regimen leads to complete regression of corneal ulcer. This report highlights the fact that early and accurate identification and therapy can resolve keratitis caused by rare pathogen C. gloeosporioides.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Colletotrichum gloeosporioides; Internal transcribed spacer sequence; Keratitis

Mesh:

Substances:

Year:  2017        PMID: 28501467     DOI: 10.1016/j.mycmed.2017.04.009

Source DB:  PubMed          Journal:  J Mycol Med        ISSN: 1156-5233            Impact factor:   2.391


  3 in total

1.  Therapeutic Penetrating Keratoplasty in a Case of Corneal Perforation Caused by Colletotrichum gloeosporioides Infection.

Authors:  Kazuki Imai; Takayoshi Sumioka; Hiroki Iwanishi; Yukihisa Takada; Shin'ichi Murata; Ryuta Iwamoto; Yuka Okada; Shizuya Saika
Journal:  Pathogens       Date:  2022-04-29

2.  [Fungal keratitis caused by Colletotrichum gloeosporioides: A case report].

Authors:  I Zakariya-Yousef Breval; A Márquez Sanabria; A Guzmán González; A Tenorio Abreu
Journal:  Rev Esp Quimioter       Date:  2019-03-06       Impact factor: 1.553

3.  Distribution of Pathogenic Yeasts in Different Clinical Samples: Their Identification, Antifungal Susceptibility Pattern, and Cell Invasion Assays.

Authors:  Satish T Pote; Mahesh S Sonawane; Praveen Rahi; Sunil R Shah; Yogesh S Shouche; Milind S Patole; Madhuri R Thakar; Rohit Sharma
Journal:  Infect Drug Resist       Date:  2020-04-20       Impact factor: 4.003

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.